Vir Biotechnology, Inc. ( VIR) - Stock Earnings
VIR Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 4, 2026, midnight | — / — | — | — / — | — |
VIR Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -42.9 million USD | 64.1 million USD |
| 2026Q1 | -125.7 million USD | -29000 USD |
| 2026Q2 | 80.1 million USD | 238.9 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
VIR Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -615.1 million USD | 86.2 million USD |
| 2024 | -522.0 million USD | 74.2 million USD |
| 2025 | -438.0 million USD | 68.6 million USD |
| 2026 Est. | — | — |
VIR
Price: $10.47
52 week price:
Earnings Per Share: -1.78 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 703157
Market Capitalization: 1.9 billion